FDA approves tecovirimat as treatment of smallpox


eMediNexus    14 July 2018

The US Food and Drug Administration (FDA) has approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Although, small pox was declared as eradicated in 1980 by the WHO, there have been longstanding concerns that smallpox could be used as a bioweapon.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.